Dopamine and schizophrenia-a cortically corrective perspective

George E. Jaskiw, Daniel Weinberger

Research output: Contribution to journalArticle

Abstract

The traditional dopamine hypothesis holds that excessive striatal/limbic dopamine-mediated transmission is causally related to the pathophysiology of schizophenia. However, schizophrenia is not cured by dopamine blocking drugs and is associated with relatively few replicable, direct indices of dopamine-mediated dysregulation. In comparison, the evidence supporting limbic and neocortical abnormalities in schizophrenia is robust. In light of what is known about these cortical abnormalities and about brain development and connectivity, the overall research data point to an early pathological process affecting temporal-limbic and/or prefrontal cortices which becomes clinically manifested later in life. To the extent that dopamine dysregulation may be a factor in the expression of some schizophrenic symptoms, it probably represents a secondary, 'downstream' effect of the cortical abnormalities. A number of possible mechanisms are described that might explain the relationship between cortical abnormalities and dopamine dysregulation in schizophrenia.

Original languageEnglish (US)
Pages (from-to)179-188
Number of pages10
JournalSeminars in Neuroscience
Volume4
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Dopamine
Schizophrenia
Corpus Striatum
Dopamine Agents
Pathologic Processes
Temporal Lobe
Prefrontal Cortex
Brain
Research

Keywords

  • limbic
  • neurodevelopment
  • prefrontal cortex
  • striatum
  • temporal lobe

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Dopamine and schizophrenia-a cortically corrective perspective. / Jaskiw, George E.; Weinberger, Daniel.

In: Seminars in Neuroscience, Vol. 4, No. 2, 1992, p. 179-188.

Research output: Contribution to journalArticle

@article{4fb1558c00954b97950788afadc58c8f,
title = "Dopamine and schizophrenia-a cortically corrective perspective",
abstract = "The traditional dopamine hypothesis holds that excessive striatal/limbic dopamine-mediated transmission is causally related to the pathophysiology of schizophenia. However, schizophrenia is not cured by dopamine blocking drugs and is associated with relatively few replicable, direct indices of dopamine-mediated dysregulation. In comparison, the evidence supporting limbic and neocortical abnormalities in schizophrenia is robust. In light of what is known about these cortical abnormalities and about brain development and connectivity, the overall research data point to an early pathological process affecting temporal-limbic and/or prefrontal cortices which becomes clinically manifested later in life. To the extent that dopamine dysregulation may be a factor in the expression of some schizophrenic symptoms, it probably represents a secondary, 'downstream' effect of the cortical abnormalities. A number of possible mechanisms are described that might explain the relationship between cortical abnormalities and dopamine dysregulation in schizophrenia.",
keywords = "limbic, neurodevelopment, prefrontal cortex, striatum, temporal lobe",
author = "Jaskiw, {George E.} and Daniel Weinberger",
year = "1992",
doi = "10.1016/1044-5765(92)90016-U",
language = "English (US)",
volume = "4",
pages = "179--188",
journal = "Seminars in the Neurosciences",
issn = "1044-5765",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Dopamine and schizophrenia-a cortically corrective perspective

AU - Jaskiw, George E.

AU - Weinberger, Daniel

PY - 1992

Y1 - 1992

N2 - The traditional dopamine hypothesis holds that excessive striatal/limbic dopamine-mediated transmission is causally related to the pathophysiology of schizophenia. However, schizophrenia is not cured by dopamine blocking drugs and is associated with relatively few replicable, direct indices of dopamine-mediated dysregulation. In comparison, the evidence supporting limbic and neocortical abnormalities in schizophrenia is robust. In light of what is known about these cortical abnormalities and about brain development and connectivity, the overall research data point to an early pathological process affecting temporal-limbic and/or prefrontal cortices which becomes clinically manifested later in life. To the extent that dopamine dysregulation may be a factor in the expression of some schizophrenic symptoms, it probably represents a secondary, 'downstream' effect of the cortical abnormalities. A number of possible mechanisms are described that might explain the relationship between cortical abnormalities and dopamine dysregulation in schizophrenia.

AB - The traditional dopamine hypothesis holds that excessive striatal/limbic dopamine-mediated transmission is causally related to the pathophysiology of schizophenia. However, schizophrenia is not cured by dopamine blocking drugs and is associated with relatively few replicable, direct indices of dopamine-mediated dysregulation. In comparison, the evidence supporting limbic and neocortical abnormalities in schizophrenia is robust. In light of what is known about these cortical abnormalities and about brain development and connectivity, the overall research data point to an early pathological process affecting temporal-limbic and/or prefrontal cortices which becomes clinically manifested later in life. To the extent that dopamine dysregulation may be a factor in the expression of some schizophrenic symptoms, it probably represents a secondary, 'downstream' effect of the cortical abnormalities. A number of possible mechanisms are described that might explain the relationship between cortical abnormalities and dopamine dysregulation in schizophrenia.

KW - limbic

KW - neurodevelopment

KW - prefrontal cortex

KW - striatum

KW - temporal lobe

UR - http://www.scopus.com/inward/record.url?scp=0037952069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037952069&partnerID=8YFLogxK

U2 - 10.1016/1044-5765(92)90016-U

DO - 10.1016/1044-5765(92)90016-U

M3 - Article

AN - SCOPUS:0037952069

VL - 4

SP - 179

EP - 188

JO - Seminars in the Neurosciences

JF - Seminars in the Neurosciences

SN - 1044-5765

IS - 2

ER -